Genomics

Sid Sijbrandij's osteosarcoma dataset

Sid was diagnosed with osteosarcoma in November 2022 and after running out of standard of care treatment options he began: maximum diagnostics, created new treatments, started doing treatments in parallel, and scaling this for others. This dataset includes the clinical and molecular data generated by and for Sid throughout this journey: longitudinal single cell and bulk RNA and DNA sequencing, spatial transcriptomics, residual disease testing (MRD), flow cytometry, imaging, and clinical lab results. This data is being freely shared with the community to advance cancer research.

Listed for discovery. Access is provided by the original publisher under its terms.

Data coverage

Access & permitted use

Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.

CC0 1.0; https://creativecommons.org/publicdomain/zero/1.0/

Need help sourcing data?

Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.

Request sourcing help

Related data sources

Clinical trialsOpen API

ClinicalTrials.gov Study Records

Registered clinical studies, recruitment status, interventions, conditions, sponsors and reported results. Searchable structured records available through the ClinicalTrials.gov API.

ClinicalTrials.gov / U.S. National Library of Medicine

Drug safetyOpen API

FDA Drug Adverse Event Reports

Publicly releasable drug adverse event and medication error reports drawn from FAERS, provided as queryable JSON through openFDA.

U.S. Food and Drug Administration

Population healthPublic download

CDC BRFSS 2025 Survey Microdata

Annual U.S. behavioral risk-factor survey covering chronic conditions, health behaviors and preventive care. The 2025 release contains 356,158 survey records.

Centers for Disease Control and Prevention